Effect of Medication on Ejection Fraction and Quality of Life in Patients with Heart Disease

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v4i4.1465

Irfan Ullah

School of Clinical Medical, Inner Mongolia Minzu University, Tongliao 028000, Inner Mongolia, China

Abstract

Ejection fraction and quality of life in patients with heart disease are important indicators for assessing cardiac function and treatment outcomes. This research investigated the effect of medication on ejection fraction and quality of life in patients with heart disease. Through a randomized controlled trial, this research observed the changes in ejection fraction and quality of life in patients who received medication compared with those who did not. The results showed that medication significantly improved the patients’ ejection fraction and also showed improvement in quality of life. These findings provide strong evidence for the pharmacological treatment of heart disease and emphasize its importance in improving patients’ quality of life. It highlights the significant effect of pharmacological treatment in improving ejection fraction and quality of life in patients with heart disease, and provides a solid scientific basis for the treatment of heart disease, which is a positive effect for patients and physicians concerned about heart health.

Keywords

medication, ejection fraction, quality of life, heart disease, randomized controlled trial

Full Text

PDF - Viewed/Downloaded: 3 Times

References

[1] Sang Hu, Li Zhang, Chunlin He, et al. Analysis of influencing factors on drug compliance of patients with coronary atherosclerotic heart disease after percutaneous coronary intervention [J]. Chinese Journal of Clinicians. 2023; 51 (08): 928-931.
[2] Yang Zhou. Expert consensus on drug treatment management path for patients with coronary atherosclerotic heart disease [J]. Journal of Clinical Drug Therapy. 2023; 21 (06): 1-18.
[3] Lizhu Han, Qinan Yin, Yuan Bian et al. Interpretation of the Consensus Document of the European Heart Association: Patient Characteristics of Heart Failure Adjusted Drug Therapy [J]. Medical Journal. 2022; 41 (07): 937-941.
[4] Yaming Yang, Guoan Zhao, Chunyu Feng, et al. Research progress on lipid metabolism mechanism and drug therapy in patients with coronary atherosclerotic heart disease [J]. Journal of Xinxiang Medical College. 2021; 38 (10): 996-1000.
[5] Sen Bai. Effects of intensive statin treatment on blood lipids, arterial endothelial function, and myocardial energy metabolism in patients with coronary atherosclerotic heart disease diagnosed for the first time [J]. China Pharmacoeconomics. 2021; 16 (09): 111-114+120.
[6] Yanni Ma. Efficacy of different statins in treating patients with hyperlipidemia and coronary atherosclerotic heart disease [J]. China Pharmacoeconomics. 2021; 16 (08): 88-91+95.

Citing this article:

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License